- Conditions
- Dry Eye
- Interventions
- Restylane Defyne
- Device
- Lead sponsor
- John C Meyer, MD
- Other
- Eligibility
- 21 Years to 80 Years
- Enrollment
- 17 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2019
- U.S. locations
- 1
- States / cities
- Louisville, Kentucky
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–20
of 20
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Nasolabial Folds, Wrinkles
- Interventions
- TEOSYAL® RHA Global Action, TEOSYAL® RHA Deep Lines
- Device
- Lead sponsor
- Teoxane SA
- Industry
- Eligibility
- 22 Years and older
- Enrollment
- 148 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2016
- U.S. locations
- 5
- States / cities
- Birmingham, Alabama • Beverly Hills, California • Santa Monica, California + 2 more
- Conditions
- Wrinkle, Nasolabial Fold, Aging
- Interventions
- Split-face injection of RHA® 4 with a cannula into a single NLF., Split-face injection of RHA® 4 with a needle (TSK 27G x ½") into the contralateral NLF.
- Device
- Lead sponsor
- Teoxane SA
- Industry
- Eligibility
- 22 Years and older
- Enrollment
- 50 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2021
- U.S. locations
- 4
- States / cities
- Encinitas, California • West Palm Beach, Florida • Chapel Hill, North Carolina + 1 more
- Conditions
- Aging, Pain
- Interventions
- RHA®4 with new anesthetic agent, RHA®4-Lidocaine
- Device
- Lead sponsor
- Teoxane SA
- Industry
- Eligibility
- 22 Years and older
- Enrollment
- 30 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2019 – 2020
- U.S. locations
- 3
- States / cities
- Beverly Hills, California • Coral Gables, Florida • Chicago, Illinois
- Conditions
- Contraception
- Interventions
- SILCS Diaphragm, Nonoxynol-9 Gel, Buffer Gel
- Device · Combination Product
- Lead sponsor
- CONRAD
- Other
- Eligibility
- 18 Years to 40 Years
- Enrollment
- 450 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2008 – 2009
- U.S. locations
- 6
- States / cities
- Los Angeles, California • Baltimore, Maryland • Philadelphia, Pennsylvania + 3 more
- Conditions
- Infra-orbital Hollows, Tear-trough Deformity, Wrinkle
- Interventions
- RHA® Redensity Eye
- Device
- Lead sponsor
- Teoxane SA
- Industry
- Eligibility
- 22 Years and older
- Enrollment
- 248 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2020 – 2025
- U.S. locations
- 4
- States / cities
- Encino, California • Santa Monica, California • Coral Gables, Florida + 1 more
- Conditions
- Pain, Aging
- Interventions
- RHA® Redensity with new anesthetic agent, RHA® Redensity with lidocaine
- Device
- Lead sponsor
- Teoxane SA
- Industry
- Eligibility
- 22 Years and older
- Enrollment
- 20 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2024 – 2025
- U.S. locations
- 2
- States / cities
- Birmingham, Alabama • New York, New York
- Conditions
- Cheek Augmentation, Correction of Age-related Midface Contour Deficiencies
- Interventions
- injection of RHA®4 in Midface, injection of Comparator Product in Midface
- Device
- Lead sponsor
- Teoxane SA
- Industry
- Eligibility
- 22 Years and older
- Enrollment
- 201 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2021 – 2024
- U.S. locations
- 1
- States / cities
- Chestnut Hill, Massachusetts
- Conditions
- Nasolabial Folds, Wrinkles
- Interventions
- TEOSYAL® RHA Ultra Deep
- Device
- Lead sponsor
- Teoxane SA
- Industry
- Eligibility
- 22 Years and older
- Enrollment
- 140 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2016
- U.S. locations
- 4
- States / cities
- Beverly Hills, California • Bradenton, Florida • Chapel Hill, North Carolina + 1 more
- Conditions
- Atopic Dermatitis
- Interventions
- ShA9 Topical Gel, Hydrocortisone Ointment, Clobetasol Ointment, Fluocinonide Ointment, Placebo (Vehicle) Topical Gel, Triamcinolone Ointment
- Drug
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Eligibility
- 6 Years and older
- Enrollment
- 86 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2027
- U.S. locations
- 8
- States / cities
- San Diego, California • Denver, Colorado • Chicago, Illinois + 4 more
- Conditions
- Perioral Rhytids, Aging, Wrinkle
- Interventions
- TEOSYAL RHA Redensity
- Device
- Lead sponsor
- Teoxane SA
- Industry
- Eligibility
- 22 Years and older
- Enrollment
- 202 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2016 – 2019
- U.S. locations
- 6
- States / cities
- Beverly Hills, California • Santa Monica, California • Coral Gables, Florida + 3 more
- Conditions
- Wrinkles
- Interventions
- Elevess
- Device
- Lead sponsor
- Anika Therapeutics, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 100 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2009 – 2010
- U.S. locations
- 9
- States / cities
- Los Angeles, California • Boca Raton, Florida • Coral Gables, Florida + 6 more
- Conditions
- HIV Infections
- Interventions
- Acidform Lubricant, HEC gel
- Drug
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Eligibility
- 18 Years to 50 Years · Female only
- Enrollment
- 35 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- Started 2009
- U.S. locations
- 1
- States / cities
- The Bronx, New York
- Conditions
- Aging, Pain
- Interventions
- RHA® Redensity with new anesthetic agent, RHA® Redensity with lidocaine
- Device
- Lead sponsor
- Teoxane SA
- Industry
- Eligibility
- 22 Years and older
- Enrollment
- 30 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2019 – 2020
- U.S. locations
- 3
- States / cities
- Beverly Hills, California • Coral Gables, Florida • Chicago, Illinois
- Conditions
- Plasmodium Falciparum Malaria
- Interventions
- AMA1-C1/Alhydrogel®, CPG 7909 Oligodeoxynucleotide (VaxImmune®)
- Biological
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Eligibility
- 18 Years to 45 Years
- Enrollment
- 75 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2005 – 2007
- U.S. locations
- 1
- States / cities
- Rochester, New York
- Conditions
- Mild to Moderate Dry Eye Disease
- Interventions
- Restylane Defyne
- Device
- Lead sponsor
- John C Meyer, MD
- Other
- Eligibility
- 21 Years to 80 Years
- Enrollment
- 14 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018
- U.S. locations
- 1
- States / cities
- Louisville, Kentucky
- Conditions
- Osteoarthritis Knee
- Interventions
- Gel-One, PBS
- Device
- Lead sponsor
- Seikagaku Corporation
- Industry
- Eligibility
- 40 Years to 80 Years
- Enrollment
- 814 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2016
- U.S. locations
- 41
- States / cities
- Birmingham, Alabama • Sheffield, Alabama • Phoenix, Arizona + 38 more
- Conditions
- Contraception, Pain, Acute, Anesthesia, Local
- Interventions
- Buffered Lidocaine, Sham Comparator, Unbuffered lidocaine, Xylocaine jelly 2%, Surgilube
- Drug · Other
- Lead sponsor
- University of California, San Diego
- Other
- Eligibility
- 18 Years to 50 Years · Female only
- Enrollment
- 204 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2025 – 2028
- U.S. locations
- 1
- States / cities
- La Jolla, California
- Conditions
- Lip Augmentation, Lip
- Interventions
- RHA 3, Restylane-L
- Device
- Lead sponsor
- Teoxane SA
- Industry
- Eligibility
- 22 Years and older
- Enrollment
- 202 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2020 – 2022
- U.S. locations
- 1
- States / cities
- Bradenton, Florida
- Conditions
- Osteoarthritis, Knee
- Interventions
- Zilretta, Synvisc-One 48 MG in 6 ML Prefilled Syringe, Monovisc 88 MG Per 4 ML Prefilled Syringe
- Drug
- Lead sponsor
- Ohio State University
- Other
- Eligibility
- 25 Years to 85 Years
- Enrollment
- 6 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2023
- U.S. locations
- 2
- States / cities
- Columbus, Ohio • Lewis Center, Ohio